Ionis Pharmaceuticals
IONS
339 hedge funds and large institutions have $6.45B invested in Ionis Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 117 increasing their positions, 98 reducing their positions, and 26 closing their positions.
223% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 26
19% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 98
19% more funds holding
Funds holding: 285 → 339 (+54)
1% more capital invested
Capital invested by funds: $6.4B → $6.45B (+$47.4M)
4% less call options, than puts
Call options by funds: $108M | Put options by funds: $113M
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$56.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.3M |
| 3 |
Goldman Sachs
New York
|
+$44.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$40.1M |
| 5 |
ClearBridge Investments
New York
|
+$37.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$247M |
| 2 |
Jennison Associates
New York
|
-$107M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$80.7M |
| 4 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
-$28.6M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$23M |
IONS Hedge Fund Activity: Q1 2015 in Review
339 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q1 2015, worth a combined $6.45B — up 0.74% from $6.4B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new IONS positions and 26 closed out — a net gain of 58 holders — while 117 added to existing stakes and 98 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $56.1M. The largest seller was Artisan Partners, cutting an estimated $247M.
- 339 institutional investors held Ionis Pharmaceuticals (IONS) as of Q1 2015, up from 285 in Q4 2014.
- Funds reported $6.45B of Ionis Pharmaceuticals stock for Q1 2015, up 0.74% quarter-over-quarter.
- 84 funds opened new Ionis Pharmaceuticals positions in Q1 2015 and 26 closed out, a net change of +58 holders.
- The largest Ionis Pharmaceuticals buyer in Q1 2015 was Wellington Management Group, an estimated $56.1M added.
- The largest Ionis Pharmaceuticals seller in Q1 2015 was Artisan Partners, an estimated $247M sold.
Based on aggregated 13F filings for Q1 2015.